Antiinflammatory therapy outcomes for mild OSA in children

Chest

Volumn 146, Issue 1, 2014, Pages 88-95

  Kheirandish Gozal, Leila ^a   Bhattacharjee, Rakesh ^a   Bandla, Hari P R ^a   Gozal, David ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MONTELUKAST;

ADENOTONSILLECTOMY; ADOLESCENT; ANTIINFLAMMATORY THERAPY; ARTICLE; CHILD; CLINICAL EXAMINATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT IDENTIFICATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; POLYSOMNOGRAPHY; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84903646202     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2288     Document Type: Article

References (39)

1. Marcus CL, Brooks LJ, Draper KA, et al; American Acad emy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012; 130 (3): e714 - e755.
2. Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, et al. Ade notonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med. 2010; 182 (5): 676-683.
3. Marcus CL, Moore RH, Rosen CL, et al; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013; 368 (25): 2366-2376.
4. Kheirandish-Gozal L, Kim J, Goldbart AD, Gozal D. Novel pharmacological approaches for treatment of obstructive sleep apnea in children. Expert Opin Investig Drugs. 2013; 22 (1): 71-85.
5. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifi er therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005; 172 (3): 364-370.
6. Kuhle S, Urschitz MS. Anti-infl ammatory medications for obstructive sleep apnea in children. Cochrane Database Syst Rev. 2011;(1): CD007074.
7. Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics. 2012; 130 (3): e575 - e580.
8. Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifi er therapy in residual sleepdisordered breathing aft er tonsillectomy and adenoidectomy in children. Pediatrics. 2006; 117 (1): e61 - e66.
9. Esteitie R, Emani J, Sharma S, Suskind DL, Baroody FM. Eff ect of fl uticasone furoate on interleukin 6 secretion from adenoid tissues in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 2011; 137 (6): 576-582.
10. Zhang L, Mendoza-Sassi RA, César JA, Chadha NK. Intra nasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev. 2008;(3): CD006286.
11. Kheirandish-Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syn drome. Pediatrics. 2008; 122 (1): e149 - e155.
12. Alexopoulos EI, Kaditis AG, Kalampouka E, et al. Nasal corticosteroids for children with snoring. Pediatr Pulmonol. 2004; 38 (2): 161-167.
13. Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol. 2004; 92 (2): 255-261.
14. Mansfi eld LE, Diaz G, Posey CR, Flores-Neder J. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol. 2004; 92 (2): 240-244.
15. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Effi cacy of fl uticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr. 2001; 138 (6): 838-844.
16. Dayyat E, Serpero LD, Kheirandish- Gozal L, et al. Leuko t riene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest. 2009; 135 (5): 1142-1149.
17. Kheirandish-Gozal L, Serpero LD, Dayyat E, et al. Corti costeroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea. Eur Respir J. 2009; 33 (5): 1077-1084.
18. Brodsky L, Moore L, Stanievich JF. A comparison of tonsillar size and oropharyngeal dimensions in children with obstructive adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 1987; 13 (2): 149-156.
19. Mallampati SR, Gatt SP, Gugino LD, et al. A clinical sign to predict diffi cult tracheal intubation: a prospective study. Can Anaesth Soc J. 1985; 32 (4): 429-434.
20. Bhattacharjee R, Dayyat E, Kheirandish- Gozal L, Sans Capdevila O, Gozal D. Nocturnal polysomnographic characteristics of habitually snoring children initially referred to pedi atric ENT or sleep clinics. Sleep Med. 2009; 10 (9): 1031-1034.
21. Dayyat E, Kheirandish-Gozal L, Sans Capdevila O, Maarafeya MM, Gozal D. Obstructive sleep apnea in children: relative contributions of body mass index and adenotonsillar hypertrophy. Chest. 2009; 136 (1): 137-144.
22. What is epi info? Centers for Disease Control and Prevention website. http://www.cdc.gov/epiinfo/.AccessedAugust16,2013.
23. Kuczmarski RJ, Ogden CL, Grummer- Strawn LM, et al. CDC growth charts: United States. Adv Data. 2000; 314(314): 1-27.
24. Iber C, Chesson A, Quan SF; American Academy of Sleep Medicine. The AASM Manual for Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifi cations. 1st ed. Westchester, IL: American Academy of Sleep Medicine; 2007.
25. Montgomery-Downs HE, O'Brien LM, Gulliver TE, Gozal D. Polysomnographic characteristics in normal preschool and early school-aged children. Pediatrics. 2006; 117 (3): 741-753.
26. Tauman R, Gulliver TE, Krishna J, et al. Persistence of obstructive sleep apnea syndrome in children aft er adenotonsillectomy. J Pediatr. 2006; 149 (6): 803-808.
27. Mitchell RB. Adenotonsillectomy for obstructive sleep apnea in children: outcome evaluated by pre- and postoperative polysomnography. Laryngoscope. 2007; 117 (10): 1844-1854.
28. Subramanyam R, Varughese A, Willging JP, Sadhasivam S. Future of pediatric tonsillectomy and perioperative outcomes. Int J Pediatr Otorhinolaryngol. 2013; 77 (2): 194-199.
29. Bixler EO, Vgontzas AN, Lin HM, et al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep. 2009; 32 (6): 731-736.
30. Gozal D, Kheirandish-Gozal L. Childhood obesity and sleep: relatives, partners, or both?a critical perspective on the evidence. Ann N Y Acad Sci. 2012; 1264: 135-141.
31. Verhulst SL, Schrauwen N, Haentjens D, et al. Sleep-disordered breathing in overweight and obese children and adolescents: prevalence, characteristics and the role of fat distribution. Arch Dis Child. 2007; 92 (3): 205-208.
32. Arens R, Sin S, Nandalike K, et al. Upper airway structure and body fat composition in obese children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2011; 183 (6): 782-787.
33. Kheirandish-Gozal L. Fat and lymphadenoid tissues: a mutually obstructive combination. Am J Respir Crit Care Med. 2011; 183 (6): 694-695.
34. Grade Working Group. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group website. http://www. gradeworkinggroup.org.AccessedNovember10,2013.
35. Ansari MT, Tsertsvadze A, Moher D. Grading quality of evidence and strength of recommendations: a perspective. PLoS Med. 2009; 6 (9): e1000151.
36. Ratner PH, Miller SD, Hampfel FC Jr, Melchior A, Dunbar SA, Tantry SK. Once-daily treatment with beclomethasone dipropionate nasal aerosol does not aff ect hypothalamic-pituitary-adrenal axis function. Ann Allergy Asthma Immunol. 2012; 109 (5): 336-341.
37. Ratner PH, Meltzer EO, Teper. Mometasone furoate nasal spray is safe and eff ective for 1-year treatment of children with perennial allergic rhinitis. I nt J Pediatr Otorhinolaryngol. 2009; 73(5): 651-657.
38. Sastre J, Mosges R. Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol. 2012; 22(1): 1-12.
39. Bisgaard H, Skoner D, Boza ML, et al. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions. Pediatr Pulmonol. 2009; 44 (6): 568-579.